• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估有和无豁免的医生在治疗药物使用障碍患者方面的障碍:肯塔基州试点的横断面研究。

Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot.

机构信息

Fletcher Group, Inc, Lexington, KY, USA.

Kentucky Injury Prevention and Research Center, University of Kentucky, Lexington, KY, USA.

出版信息

J Addict Dis. 2022 Oct-Dec;40(4):518-526. doi: 10.1080/10550887.2022.2035167. Epub 2022 Mar 3.

DOI:10.1080/10550887.2022.2035167
PMID:35238283
Abstract

INTRODUCTION

Opioid and other substance use disorders (OUD/SUDs) have been and continue to be significant public health issues. The standard of care for OUD is the use of medication for opioid use disorder (MOUD) in conjunction with counseling or behavioral therapies, yet research has indicated that barriers exist for patients accessing MOUD as well as for physicians prescribing MOUD due to requirements associated with the DATA 2000 waiver.

METHODS

A pilot cross-sectional survey was conducted among Kentucky physicians in order to reassess common barriers as well as to explore barriers that non-waivered providers face to becoming waivered. Barriers were compared by waiver status (waiver vs. non-waivered) as well as geographic location (rural vs. non-rural).

RESULTS

Compared to waivered physicians, non-waivered physicians were significantly less likely to report positive personal beliefs related to the use of MOUD for OUD and reported significantly more barriers to treating OUD patients in the areas of physicians' practice and culture, auditing, and institutional support and resources ( < .05). The majority (69%) of all physicians indicated they would benefit from a tool kit with evidence-based clinical guidelines.

CONCLUSIONS

The barriers and beliefs identified in this pilot study indicate the need for policy action at the federal level to reduce barriers and incentivize more physicians to obtain waivers to treat OUD. Further, the development of brief educational resources tailored to physicians to treat OUD patients including pregnant patients with OUD is recommended.

摘要

引言

阿片类药物和其他物质使用障碍(OUD/SUD)一直是且仍是重大的公共卫生问题。阿片类药物使用障碍(OUD)的标准治疗方法是使用药物治疗(MOUD),同时辅以咨询或行为疗法,但研究表明,患者获得 MOUD 以及医生开具 MOUD 存在障碍,这是由于与 DATA 2000 豁免相关的要求所致。

方法

对肯塔基州的医生进行了一项试点横断面调查,以便重新评估常见障碍,并探讨非豁免提供者获得豁免所面临的障碍。通过豁免状态(豁免与非豁免)和地理位置(农村与非农村)比较障碍。

结果

与豁免医生相比,非豁免医生表示对 MOUD 治疗 OUD 的积极个人信念明显较低,并且在医生实践和文化、审计以及机构支持和资源等方面治疗 OUD 患者的障碍明显更多(<.05)。大多数(69%)医生表示他们将受益于包含循证临床指南的工具包。

结论

这项试点研究中确定的障碍和信念表明,需要在联邦层面采取政策行动,以减少障碍,并激励更多医生获得治疗 OUD 的豁免。此外,建议开发针对医生的简短教育资源,以治疗 OUD 患者,包括患有 OUD 的孕妇。

相似文献

1
Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot.评估有和无豁免的医生在治疗药物使用障碍患者方面的障碍:肯塔基州试点的横断面研究。
J Addict Dis. 2022 Oct-Dec;40(4):518-526. doi: 10.1080/10550887.2022.2035167. Epub 2022 Mar 3.
2
Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.放松 X 豁免培训要求后丁丙诺啡的处方特征。
JAMA Netw Open. 2024 Aug 1;7(8):e2425999. doi: 10.1001/jamanetworkopen.2024.25999.
3
Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.美国初级保健医生治疗阿片类药物使用障碍的准备情况:一项横断面调查。
Drug Alcohol Depend. 2021 Aug 1;225:108811. doi: 10.1016/j.drugalcdep.2021.108811. Epub 2021 Jun 18.
4
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.一种混合方法比较了医生对阿片类药物使用障碍药物治疗的信念和障碍的报告。
Subst Abuse Treat Prev Policy. 2020 Sep 14;15(1):69. doi: 10.1186/s13011-020-00312-3.
5
Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.《2000 年《药物成瘾治疗法》豁免:开处丁丙诺啡的障碍和促进因素调查及临床医生认知》
JAMA Netw Open. 2022 May 2;5(5):e2212419. doi: 10.1001/jamanetworkopen.2022.12419.
6
The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort study.《CARA 法案对俄勒冈州执业护士管制物质处方的影响:一项队列研究》。
Subst Abuse Treat Prev Policy. 2022 Jan 31;17(1):5. doi: 10.1186/s13011-022-00431-z.
7
Physicians' experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder.医生使用丁丙诺啡的经历:一项关于获得X豁免的动机以及开具治疗阿片类药物使用障碍药物的障碍与促进因素的定性研究。
Drug Alcohol Depend. 2023 Mar 1;244:109777. doi: 10.1016/j.drugalcdep.2023.109777. Epub 2023 Jan 16.
8
Clinician Willingness to Prescribe Medications for Opioid Use Disorder to Adolescents in Indiana.印第安纳州临床医生为青少年开阿片类药物使用障碍药物的意愿。
JAMA Netw Open. 2024 Sep 3;7(9):e2435416. doi: 10.1001/jamanetworkopen.2024.35416.
9
Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.在急诊科开始使用丁丙诺啡:对急诊临床医生的调查。
West J Emerg Med. 2024 Jul;25(4):470-476. doi: 10.5811/westjem.18029.
10
Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.护士从业者和医师助理的处方实践,以及他们在开具丁丙诺啡处方时所经历的障碍。
J Rural Health. 2020 Mar;36(2):187-195. doi: 10.1111/jrh.12404. Epub 2019 Oct 25.

引用本文的文献

1
At a Crossroads: Opioid Use Disorder, the X-Waiver, and the Road Ahead.处于十字路口:阿片类物质使用障碍、X豁免权及未来之路
Ochsner J. 2024 Summer;24(2):108-117. doi: 10.31486/toj.23.0074.
2
Integrating Opioid Use Disorder Treatment Into Primary Care Settings.将阿片类药物使用障碍治疗纳入初级保健环境中。
JAMA Netw Open. 2023 Aug 1;6(8):e2328627. doi: 10.1001/jamanetworkopen.2023.28627.
3
Disparities in Emergency Department Naloxone and Buprenorphine Initiation.急诊科纳洛酮和丁丙诺啡起始使用的差异。
West J Emerg Med. 2023 Jun 30;24(4):710-716. doi: 10.5811/westjem.58636.